111 related articles for article (PubMed ID: 12433202)
21. In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9.
Li L; Chen X; Zhou J; Zhong D
Drug Metab Dispos; 2012 Oct; 40(10):2041-53. PubMed ID: 22829543
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of dl-praeruptorin A in rat liver microsomes using HPLC-electrospray ionization tandem mass spectrometry.
Ruan H; Zhang Z; Liang XF; Fu Y; Su MQ; Liu QL; Wang XM; Zhu X
Arch Pharm Res; 2011 Aug; 34(8):1311-21. PubMed ID: 21910053
[TBL] [Abstract][Full Text] [Related]
24. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
Chung WG; Roh HK; Kim HM; Cha YN
Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
[TBL] [Abstract][Full Text] [Related]
25. Fragmentation study of imatinib and characterization of new imatinib metabolites by liquid chromatography-triple-quadrupole and linear ion trap mass spectrometers.
Marull M; Rochat B
J Mass Spectrom; 2006 Mar; 41(3):390-404. PubMed ID: 16470567
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Cresteil T
J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
[TBL] [Abstract][Full Text] [Related]
27. Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry.
Song R; Xu F; Zhang Z; Liu Y; Dong H; Tian Y
Biomed Chromatogr; 2008 Nov; 22(11):1230-6. PubMed ID: 18651591
[TBL] [Abstract][Full Text] [Related]
28. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.
Fitzpatrick JL; Ripp SL; Smith NB; Pierce WM; Prough RA
Arch Biochem Biophys; 2001 May; 389(2):278-87. PubMed ID: 11339818
[TBL] [Abstract][Full Text] [Related]
30. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
Welter J; Meyer MR; Kavanagh P; Maurer HH
Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
[TBL] [Abstract][Full Text] [Related]
31. Enzyme kinetic study of a new cardioprotective agent, KR-32570 using human liver microsomes and recombinant CYP isoforms.
Kim H; Seo KA; Kim H; Lee HS; Lee CH; Shin JG; Liu KH
Arch Pharm Res; 2007 Apr; 30(4):469-74. PubMed ID: 17489363
[TBL] [Abstract][Full Text] [Related]
32. Characterization of metabolites of a NK1 receptor antagonist, CJ-11,972, in human liver microsomes and recombinant human CYP isoforms by liquid chromatography/tandem mass spectrometry.
Prakash C; Lin J; Colizza K; Miao Z
Rapid Commun Mass Spectrom; 2007; 21(17):2822-32. PubMed ID: 17661339
[TBL] [Abstract][Full Text] [Related]
33. Characterization of rat liver microsomal and hepatocytal metabolites of brevetoxins by liquid chromatography-electrospray tandem mass spectrometry.
Wang W; Hua Y; Wang G; Cole RB
Anal Bioanal Chem; 2005 Sep; 383(1):67-75. PubMed ID: 16059676
[TBL] [Abstract][Full Text] [Related]
34. [Metabolic products and pathway of neferine in rat liver].
Huang Y; Zhao LB; Li S; Liu P; Hu BR; Wang JL; Xiang JZ
Yao Xue Xue Bao; 2007 Oct; 42(10):1034-40. PubMed ID: 18229607
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human liver cytochrome P-450 enzymes involved in the O-demethylation of a new P-glycoprotein inhibitor HM-30181.
Paek IB; Kim SY; Kim MS; Kim J; Lee G; Lee HS
J Toxicol Environ Health A; 2007 Aug; 70(15-16):1356-64. PubMed ID: 17654255
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH
Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327
[TBL] [Abstract][Full Text] [Related]
37. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats.
Kim HJ; Kim SH; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
Biopharm Drug Dispos; 2000 Oct; 21(7):279-84. PubMed ID: 11512127
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
Xu L; Woodward C; Khan S; Prakash C
Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
